Financial Performance Analysis under the Light Asset Operation Model of Tai Long Pharmaceutical Company
DOI:
https://doi.org/10.54097/5jfzy084Keywords:
Light Asset Operation, Financial Performance, Factor AnalysisAbstract
With the rapid development of the pharmaceutical industry and the increasingly fierce competition, the light asset operation model has become a key strategic choice for transforming pharmaceutical companies. This paper takes Tai Long Pharmaceutical as a case study to analyze its CXO light asset operation model and financial characteristics in depth. By employing factor analysis, a comprehensive assessment of its economic performance is conducted, and suggestions aimed at enhancing Tai Long Pharmaceutical's financial performance are proposed based on the analysis results, to help the company maintain a leading position in the fierce market competition.
Downloads
References
[1] Yu Peiyu, Cui Xiao, Yu Shunhao. A Study on the Financial Effects of Enterprise Light Asset Transformation from the Perspective of Value Chain — Taking Wanda Business Management as an Example [J]. Commercial Accounting, 2023, (01): 46-49.
[2] Li Wenxin, Guo Fanrui. A Study on the Motivation and Performance of Light Asset Operation Transformation [J]. Commercial Accounting, 2023, (18): 94-98.
[3] Guo Xinyun, Guo Hui. A Study on the Financial Performance of Enterprise Light Asset Operation Model — Taking Z Company as an Example [J]. Market Modernization, 2022, (21): 168-170.
[4] Lü Luoyi, Li Jinru. A Study on the Light Asset Operation Model and Financial Performance of the Traditional Chinese Medicine Industry — Taking Tong Ren Tang as an Example [J]. Commercial Accounting, 2024, (03): 97-101.
[5] Xie Peibo. A Study on the Impact and Path of Light Asset Operation on Enterprise Financial Risk [J]. Finance and Accounting Communication, 2024, (04): 72-76.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
